DK0445743T3 - - Google Patents

Info

Publication number
DK0445743T3
DK0445743T3 DK91103336.3T DK91103336T DK0445743T3 DK 0445743 T3 DK0445743 T3 DK 0445743T3 DK 91103336 T DK91103336 T DK 91103336T DK 0445743 T3 DK0445743 T3 DK 0445743T3
Authority
DK
Denmark
Prior art keywords
resp
chelates
bivalent
antibiotics
obtaining
Prior art date
Application number
DK91103336.3T
Other languages
Danish (da)
English (en)
Inventor
Slobodan Djokic
Zlatko Vajtner
Hrvoje Krnjevic
Nevenka Lopotar
Lidija Kolacny-Babic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of DK0445743T3 publication Critical patent/DK0445743T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91103336.3T 1990-03-07 1991-03-05 DK0445743T3 (Direct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU45590A YU45590A (sh) 1990-03-07 1990-03-07 Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje

Publications (1)

Publication Number Publication Date
DK0445743T3 true DK0445743T3 (Direct) 1997-02-17

Family

ID=25550003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103336.3T DK0445743T3 (Direct) 1990-03-07 1991-03-05

Country Status (20)

Country Link
US (1) US5498699A (Direct)
EP (1) EP0445743B1 (Direct)
JP (1) JP2731636B2 (Direct)
CN (2) CN1041166C (Direct)
AT (1) ATE143266T1 (Direct)
BG (1) BG61230B1 (Direct)
CA (1) CA2037663C (Direct)
CZ (1) CZ280181B6 (Direct)
DE (1) DE69122282T2 (Direct)
DK (1) DK0445743T3 (Direct)
ES (1) ES2094763T3 (Direct)
GR (1) GR3021947T3 (Direct)
HR (1) HRP940256B1 (Direct)
HU (2) HU209455B (Direct)
PL (1) PL166279B1 (Direct)
RO (1) RO107660B1 (Direct)
RU (2) RU2039060C1 (Direct)
SI (1) SI9010455B (Direct)
SK (1) SK279278B6 (Direct)
YU (1) YU45590A (Direct)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
TW271400B (Direct) * 1992-07-30 1996-03-01 Pfizer
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US5900410A (en) * 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
BR0211830A (pt) * 2001-08-21 2004-09-08 Pfizer Prod Inc Dose única de azitromicina
RU2283116C2 (ru) * 2002-05-27 2006-09-10 Курский государственный медицинский университет Способ увеличения выживаемости изолированного кожного лоскута "на ножке" у животных с пониженным антиоксидантным фоном
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
JP2008518025A (ja) 2004-10-25 2008-05-29 パラテック ファーマシューティカルズ インコーポレイテッド 4−アミノテトラサイクリンおよびその使用の方法
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
CN104892694A (zh) * 2015-05-24 2015-09-09 广西师范学院 蔗糖硫酸酯铜类化合物及其制作方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862225A (en) * 1961-08-18 1975-01-21 Pfizer D-ring substituted tetracyclines
US3622627A (en) * 1967-09-13 1971-11-23 Pfizer 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof
HU167946B (Direct) * 1973-04-16 1976-01-28
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
EP0206625B1 (en) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Compositions for the treatment of gastrointestinal disorders
IT1200774B (it) * 1985-10-10 1989-01-27 Pierrel Spa Procedimento di sentisi dell'amikacina
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
DE3860503D1 (de) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE391005T1 (de) * 1989-04-03 1991-04-11 Ranbaxy Laboratories, Ltd., New Delhi Verfahren zur herstellung von alpha-6-deoxytetracyclinen.
US5348946A (en) * 1991-02-28 1994-09-20 Biochem Immunosystems, Inc. Heteroanthracycline antitumor analogs
MA28714B1 (fr) * 2005-12-15 2007-07-02 Green Technlology Sarl Une arabinogalactane proteine ayant la propriete d'absorber les graisses et le procede d'obtention de cette arabinogalactane proteine

Also Published As

Publication number Publication date
BG61230B1 (bg) 1997-03-31
DE69122282T2 (de) 1997-04-24
SI9010455A (en) 1997-08-31
CN1041166C (zh) 1998-12-16
EP0445743A3 (en) 1992-10-07
SK279278B6 (sk) 1998-09-09
HRP940256A2 (en) 1997-06-30
EP0445743B1 (en) 1996-09-25
SI9010455B (sl) 2000-04-30
JPH06184186A (ja) 1994-07-05
CN1168891A (zh) 1997-12-31
ATE143266T1 (de) 1996-10-15
CN1054534A (zh) 1991-09-18
CA2037663C (en) 1999-01-19
BG93995A (bg) 1993-12-24
RO107660B1 (ro) 1993-12-30
US5498699A (en) 1996-03-12
ES2094763T3 (es) 1997-02-01
CS9100587A2 (en) 1991-10-15
HU910740D0 (en) 1991-09-30
DE69122282D1 (de) 1996-10-31
HU211475A9 (en) 1995-11-28
GR3021947T3 (en) 1997-03-31
HUT56849A (en) 1991-10-28
HU209455B (en) 1994-06-28
RU2039061C1 (ru) 1995-07-09
CN1051560C (zh) 2000-04-19
PL166279B1 (pl) 1995-04-28
YU45590A (sh) 1992-07-20
EP0445743A2 (en) 1991-09-11
CA2037663A1 (en) 1991-09-08
RU2039060C1 (ru) 1995-07-09
JP2731636B2 (ja) 1998-03-25
CZ280181B6 (cs) 1995-11-15
HRP940256B1 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
DK0445743T3 (Direct)
ZA878952B (en) Metal complex-containing pharmaceutical agents
DE69106840D1 (de) Gesinterter Körper, Sorbentmittel, und dessen Herstellungsverfahren.
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
DE59005156D1 (de) Gleitbacke für Schiebedächer, Schiebehebedächer und dergleichen.
IL97463A0 (en) Pharmaceutical composition for treating emotional numbness
FI972287L (fi) Uudenlaisia polysubstituoituja DTPA-johdoksia ja niiden metallikomplekseja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita, niiden käyttö diagnosoinnissa ja terapiassa sekä menetelmiä kyseisten kompleksinmuodostajien ja kompleksien valmistamiseksi ja menetelmiä kyseisten.
DE69016390D1 (de) Nitrierofen.
DE69101105D1 (de) Cis-platin-komplexe mit chelatierenden aminen und sulfinylcarboxylaten.
GB2239013B (en) Novel isoindole derivatives and salts thereof,processes for producing the same and antitumor agent comprising the same
NO882012L (no) Antitumor-platinakomplekser og fremgangsmaate til fremstilling derav.
ATE180148T1 (de) Differentialauszug für schubladen od.dgl.
GB2208620B (en) Seals between ceramic articles or between ceramic articles and metal articles.
DE69011806D1 (de) Gesinterter Glas-Keramikkörper und Verfahren.
ZA921716B (en) Amide-chelates,their metal complexes as well as their use in diagnosis and treatment
DE3773180D1 (de) Vorrichtung zum verhindern des aushaengens von schiebetuerlaufrollen.
AU1214792A (en) Chelates, their metal complexes as well as their use in diagnosis and treatment
DE69101652D1 (de) Behandlungsofen.
EP0409527A3 (en) Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
DE59007060D1 (de) Vorrichtung zum Herstellen von Oberflächenmuster aufweisenden Rohlingen für Klinkersteine, Ziegel und dgl.
ZA883975B (en) Treatment and diagnosis of footrot using the basic protease of b.nodosus
DE3851054D1 (de) Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen.
GR3004570T3 (Direct)
IE892341L (en) Palladium-based complexes.
NZ240384A (en) Epoxycarbacyclin derivatives and their use as precursors.